Net profit of Gland Pharma rose 6.69% to Rs 204.69 crore in the quarter ended December 2024 as against Rs 191.86 crore during the previous quarter ended December 2023. Sales declined 10.43% to Rs 1384.05 crore in the quarter ended December 2024 as against Rs 1545.16 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 1384.05 | 1545.16 | -10 |
| OPM % | 26.01 | 23.06 | - |
| PBDT | 395.63 | 388.50 | 2 |
| PBT | 299.30 | 283.16 | 6 |
| NP | 204.69 | 191.86 | 7 |